Should I buy or sell Pediatrix Medical Group stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares. View MD analyst ratings or view top-rated stocks .

What is Pediatrix Medical Group's stock price target for 2024?

4 equities research analysts have issued 1-year target prices for Pediatrix Medical Group's stock. Their MD share price targets range from $9.00 to $14.00. On average, they predict the company's share price to reach $10.30 in the next twelve months. This suggests a possible upside of 12.3% from the stock's current price. View analysts price targets for MD or view top-rated stocks among Wall Street analysts .

How have MD shares performed in 2024?

Pediatrix Medical Group's stock was trading at $9.30 at the start of the year. Since then, MD stock has decreased by 1.3% and is now trading at $9.1750. View the best growth stocks for 2024 here .

Are investors shorting Pediatrix Medical Group?

Pediatrix Medical Group saw a increase in short interest in March. As of March 15th, there was short interest totaling 4,030,000 shares, an increase of 25.2% from the February 29th total of 3,220,000 shares. Based on an average trading volume of 732,700 shares, the short-interest ratio is currently 5.5 days. Approximately 4.9% of the company's stock are short sold. View Pediatrix Medical Group's Short Interest .

When is Pediatrix Medical Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our MD earnings forecast .

How were Pediatrix Medical Group's earnings last quarter?

Pediatrix Medical Group, Inc. (NYSE:MD) posted its earnings results on Tuesday, February, 20th. The company reported $0.32 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.02. The company earned $496.44 million during the quarter, compared to analyst estimates of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive trailing twelve-month return on equity of 10.35%. The business's quarterly revenue was down 3.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.46 earnings per share.

What ETFs hold Pediatrix Medical Group's stock?

ETFs with the largest weight of Pediatrix Medical Group (NYSE:MD) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS) , Invesco S&P SmallCap 600 Pure Value ETF (RZV) , Roundhill Acquirers Deep Value ETF (DEEP) , Syntax Stratified SmallCap ETF (SSLY) and iShares U.S. Healthcare Providers ETF (IHF) . AdvisorShares Dorsey Wright Short ETF (DWSH) .

What is Mark S. Ordan's approval rating as Pediatrix Medical Group's CEO?

6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com . Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pediatrix Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA) , AbbVie (ABBV) , QUALCOMM (QCOM) , Gilead Sciences (GILD) , Pfizer (PFE) , AT&T (T) , Walt Disney (DIS) , Wells Fargo & Company (WFC) , Exxon Mobil (XOM) and Advanced Micro Devices (AMD) .

How do I buy shares of Pediatrix Medical Group?

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Positive News SentimentPositive News

NYSE:MD

Pediatrix Medical Group (MD) Stock Price, News & Analysis

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)

Free MD Stock Alerts

$9.18

-0.06 (-0.65%)

(As of 04/15/2024 ET)

Compare

Today's Range: $9.13
▼
$9.30
50-Day Range: $8.46
▼
$10.03
52-Week Range: $7.70
▼
$15.06

Volume: 459,909 shs
Average Volume: 714,871 shs
Market Capitalization: $770.98 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $10.30

Get Pediatrix Medical Group alerts:

Pediatrix Medical Group MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 12.3% Upside
$10.30 Price Target
Short Interest: Bearish
4.96% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: 2.68%
From $1.12 to $1.15 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.14 out of 5 stars

Medical Sector

846th out of 929 stocks

Hospitals Industry

3rd out of 3 stocks

2.0

Analyst's Opinion

Consensus Rating
Pediatrix Medical Group has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Pediatrix Medical Group has only been the subject of 3 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
4.96% of the float of Pediatrix Medical Group has been sold short.
Short Interest Ratio / Days to Cover
Pediatrix Medical Group has a short interest ratio ("days to cover") of 5.7.
Change versus previous month
Short interest in Pediatrix Medical Group has recently increased by 2.23%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Pediatrix Medical Group does not currently pay a dividend.
Dividend Growth
Pediatrix Medical Group does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MD.

3.2

News and Social Media Coverage

News Sentiment
Pediatrix Medical Group has a news sentiment score of 1.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Pediatrix Medical Group this week, compared to 2 articles on an average week.
MarketBeat Follows
3 people have added Pediatrix Medical Group to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pediatrix Medical Group insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.20% of the stock of Pediatrix Medical Group is held by insiders.
Percentage Held by Institutions
97.71% of the stock of Pediatrix Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Pediatrix Medical Group are expected to grow by 2.68% in the coming year, from $1.12 to $1.15 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Pediatrix Medical Group is -12.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Pediatrix Medical Group is -12.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Pediatrix Medical Group has a PEG Ratio of 2.50. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Pediatrix Medical Group has a P/B Ratio of 0.91. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

Forget Nvidia, buy this A.I. Stock Now

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

Click here to see the details.

About Pediatrix Medical Group Stock (NYSE:MD)

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

MD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MD Stock News Headlines

April 7, 2024 | finance.yahoo.com

Pediatrix Medical Group (NYSE:MD shareholders incur further losses as stock declines 6.5% this week, taking five-year losses to 66%

March 18, 2024 | yahoo.com

MDs Explain the Causes — and Cures — for Period Diarrhea

April 16, 2024 | Porter & Company (Ad)

The #1 Investment of the Decade…

Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.

March 15, 2024 | yahoo.com

Should I Try Cycle Syncing? Here's What the Experts Say

March 14, 2024 | yahoo.com

Thousands of Kids Are Going to the ER After Taking Melatonin, CDC Says

March 7, 2024 | markets.businessinsider.com

Maintaining Hold on Pediatrix Medical Group Amidst Birth Rate Trends and Financial Caution

February 22, 2024 | markets.businessinsider.com

Maintaining Hold on Pediatrix Medical Group Amidst Cost Challenges and Earnings Growth Uncertainty

February 21, 2024 | finance.yahoo.com

Pediatrix Medical Group, Inc. (NYSE:MD) Q4 2023 Earnings Call Transcript

April 16, 2024 | Porter & Company (Ad)

The #1 Investment of the Decade…

February 21, 2024 | msn.com

Bad News for Pediatrix Medical Group, Inc. Stock: This New Risk Has Been Added

February 20, 2024 | msn.com

Pediatrix Medical Group (MD) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

February 20, 2024 | benzinga.com

Recap: Pediatrix Medical Group Q4 Earnings

February 20, 2024 | msn.com

Pediatrix Medical Group reports mixed Q4 results; initiates FY24 outlook

February 20, 2024 | finance.yahoo.com

Pediatrix Medical Group Inc (MD) Reports Q4 Loss and Revenue Decline Amid Operational Challenges

February 20, 2024 | businesswire.com

Pediatrix Medical Group Reports Fourth Quarter Results

February 19, 2024 | benzinga.com

Earnings Preview For Pediatrix Medical Group

February 15, 2024 | msn.com

Will High Expenses Ail Pediatrix Medical's (MD) Q4 Earnings?

February 13, 2024 | finance.yahoo.com

Pediatrix® Medical Group to Host National Neonatology Meetings Feb. 19-24

February 7, 2024 | markets.businessinsider.com

Pediatrix Medical Group: Hold Rating Amidst Declining Birth Rates and Cost Inflation Concerns

February 7, 2024 | finance.yahoo.com

Pediatrix Medical Group 2023 Fourth Quarter Conference Call/Webcast Scheduled for Tuesday, February 20, 2024

February 7, 2024 | msn.com

The #1 Sign of Cervical Cancer Most People Miss

January 23, 2024 | yahoo.com

If Your Period Is Suddenly Way Lighter, It May Be Related To A Hormone Imbalance

January 16, 2024 | msn.com

Winter weather: What parents need to know about keeping kids safe during extreme cold

January 15, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: PTC Therapeutics (PTCT), Regeneron (REGN) and Pediatrix Medical Group (MD)

January 12, 2024 | msn.com

Your Guide to Baby Sleep Regressions

January 4, 2024 | yahoo.com

What You Need to Know About Vaginal pH Soap Bars

December 12, 2023 | markets.businessinsider.com

Hold Rating on Pediatrix Medical Group Amidst Challenging Financial Outlook and Cost Inflation Concerns

See More Headlines

Receive MD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/20/2024
Today: 4/16/2024
Next Earnings (Estimated): 5/07/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Hospitals
Sub-Industry: Health Care Services
Current Symbol: NYSE:MD
Previous Symbol: NYSE:PDX
CUSIP: 58502B10
CIK: 893949
Web: www.mednax.com
Phone: (954) 384-0175
Fax: 954-838-9961
Employees: 5,170
Year Founded: 1979

Price Target and Rating

Average Stock Price Target: $10.30
High Stock Price Target: $14.00
Low Stock Price Target: $9.00
Potential Upside/Downside: +12.3%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.73)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 8.19
P/E Growth: 2.5
Net Income: $-60,410,000.00
Net Margins: -3.03%
Pretax Margin: -2.42%
Return on Equity: 10.35%
Return on Assets: 4.14%

Debt

Debt-to-Equity Ratio: 0.73
Current Ratio: 1.24
Quick Ratio: 1.24

Sales & Book Value

Annual Sales: $1.99 billion
Price / Sales: 0.39
Cash Flow: $1.56 per share
Price / Cash Flow: 5.89
Book Value: $10.10 per share
Price / Book: 0.91

Miscellaneous

Outstanding Shares: 84,030,000
Free Float: 83,018,000
Market Cap: $770.98 million
Optionable: Optionable
Beta: 1.58

Social Links

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Dr. James D. Swift M.D. (Age 61)
CEO & Director
Comp: $1.21M
Mr. C. Marc Richards (Age 53)
Executive VP & CFO
Comp: $850.33k
Ms. Debra Kaspar
President of North Market
Mr. Kevin Pitzer
President of Southwest Market
Mr. Mike Ashford
President of Southeast Texas Market
Dr. Michael Dwyer M.D.
President of Texas Market
Ms. Nanette Sanders
President of West Coast Market
Ms. Suzanne Heck
President of East Market
Ms. Linda Chen
South Market President
Dr. David Kanter C.P.C.
M.B.A., M.D., Senior Vice President of Medical Administrative Services

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MD Stock Analysis - Frequently Asked Questions

Should I buy or sell Pediatrix Medical Group stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares.
View MD analyst ratings or view top-rated stocks.
What is Pediatrix Medical Group's stock price target for 2024?: 4 equities research analysts have issued 1-year target prices for Pediatrix Medical Group's stock. Their MD share price targets range from $9.00 to $14.00. On average, they predict the company's share price to reach $10.30 in the next twelve months. This suggests a possible upside of 12.3% from the stock's current price.
View analysts price targets for MD or view top-rated stocks among Wall Street analysts.
How have MD shares performed in 2024?: Pediatrix Medical Group's stock was trading at $9.30 at the start of the year. Since then, MD stock has decreased by 1.3% and is now trading at $9.1750.
View the best growth stocks for 2024 here.
Are investors shorting Pediatrix Medical Group?: Pediatrix Medical Group saw a increase in short interest in March. As of March 15th, there was short interest totaling 4,030,000 shares, an increase of 25.2% from the February 29th total of 3,220,000 shares. Based on an average trading volume of 732,700 shares, the short-interest ratio is currently 5.5 days. Approximately 4.9% of the company's stock are short sold.
View Pediatrix Medical Group's Short Interest.
When is Pediatrix Medical Group's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our MD earnings forecast.
How were Pediatrix Medical Group's earnings last quarter?: Pediatrix Medical Group, Inc. (NYSE:MD) posted its earnings results on Tuesday, February, 20th. The company reported $0.32 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.02. The company earned $496.44 million during the quarter, compared to analyst estimates of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive trailing twelve-month return on equity of 10.35%. The business's quarterly revenue was down 3.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.46 earnings per share.

What ETFs hold Pediatrix Medical Group's stock?: ETFs with the largest weight of Pediatrix Medical Group (NYSE:MD) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap 600 Pure Value ETF (RZV), Roundhill Acquirers Deep Value ETF (DEEP), Syntax Stratified SmallCap ETF (SSLY) and iShares U.S. Healthcare Providers ETF (IHF).AdvisorShares Dorsey Wright Short ETF (DWSH).
What is Mark S. Ordan's approval rating as Pediatrix Medical Group's CEO?: 6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com. Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Pediatrix Medical Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).
How do I buy shares of Pediatrix Medical Group?: Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:MD) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial